Global Gastrointestinal Stents (Esophageal, Duodenal/Pyloric And Colorectal) Market
The global gastrointestinal stents (esophageal, duodenal/pyloric and colorectal) market is forecast to reach US$118.9 million in 2015 according to the new report “Non-Vascular Stents Market Assessment & Forecast: 2015 - 2019” by SA-Business Research & Consulting group.
There are primarily three groups of stents that comprise the total global non-vascular stents. The report includes analysis for gastrointestinal stents (esophageal, duodenal/pyloric and colorectal). The research also includes analysis of urological stents such as J-stents, double J-stents and prostatic stents. Along with this, the market for other non-vascular stents such as biliary and pulmonary stents was also analyzed. Colorectal cancer accounts for the largest incidence, hence the rate of procedures performed to treat blockages in colorectal section comprises the greatest value for the gastrointestinal segment. Considering combined estimations from Cancer Research UK, Center for Diseases Control and National Cancer Institute, there are approximately 1 million new cases of colorectal cancer each year. Of these diagnosed cases, approximately 10% to 30% present complete or partial obstruction of the colon which represents eligibility for colorectal stenting. Achalasia occurs in over 1 person per 100,000. According to our estimated approximately 15,000 esophageal stenting procedures were carried out across the world in 2014 to treat malignant strictures. A large majority of them were carried out in developed countries such as United States and United Kingdom, France, Germany and Japan.
Request Free Report Sample@ http://www.sa-brc.com/Global-Non-Vascular-Stents-Market-Assessment--Forecast-2015---2019/sample17
Ureteral stents segment accounted for the largest revenue generation and is expected to lead till the end of the forecast, primarily due to a larger number of factors that provide eligibility for stent implantation such as prostate swelling, BPH, kidney stones and surgical procedures that would otherwise result in blockages in the flow of urine from the kidney. Rising incidence of kidney stone cases, severity of malignant strictures and other factors for urinary incontinence are major reasons for growth of the market. However, the product segment is not without its challenges. Side-effects such as severe pain, hematuria, irritation and CAUTI or Catheter Associated Urinary Tract Infections have continued to repress the use of the device substituted by Unani medicine and therapeutic ultrasound.
More Report Description@ http://www.sa-brc.com/report/Global-Non-Vascular-Stents-Market-Assessment--Forecast-2015---2019/17
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.
Office No. 14,
Hermes Kunj, Mangaldas Road,
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Gastrointestinal Stents (Esophageal, Duodenal/Pyloric And Colorectal) Market here
News-ID: 482977 • Views: 436
More Releases from SA-BRC
Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The
More Releases for Stents
Increasing prevalence of urinary incontinence with age and rising geriatric population are major factors expected to drive the ureteral stents market growth during the forecast period. According to the Global Forum for Incontinence held in 2014, incontinence is a serious medical condition and set of diseases, which affected 4% to 8% of the population or the lives of around 400 million people worldwide over a period of 2007-2010. Furthermore, lifestyle associated
Surgical Stents Market by Cardiac Stents, Urinary Stents, Biliary Stents, Esopha …
Surgical Stent Market Scenario: The stent is a small, flexible metal or plastic tube that is inserted into the vessels or duct to keep the passageway open. Different types of materials like metal, standard polymer, and biodegradable polymer are used for the preparation of the surgical stents. According to the WHO (2015), more than 35% of the total global population was suffering from major or minor cardiovascular complications; and in 2014,
Global Enteral Stents Market For 2017: By Product Type - Esophageal Stents, Gast …
Researchmoz added Most up-to-date research on "Global Enteral Stents Market For 2017: By Product Type - Esophageal Stents, Gastroduodenal Stents & Colon Stents" to its huge collection of research reports. In this report, the global Enteral Stents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report
Global Drug Eluting Stents (DES) Market: By Types - Nitinol Stents, Platinum chr …
Researchmoz added Most up-to-date research on "Global Drug Eluting Stents (DES) Market: By Types - Nitinol Stents, Platinum chromium alloy Stents, Stainless steel Stents & Other Materials" to its huge collection of research reports. This report studies Drug Eluting Stents (DES) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast
Europe's Coronary Stent Market: By Product Type - Bare Metal Stents, Drug Elutin …
Researchmoz added Most up-to-date research on "Europe's Coronary Stent Market: By Product Type - Bare Metal Stents, Drug Eluting Stents & Bio-absorbable Stents" to its huge collection of research reports. This report studies sales (consumption) of Coronary Stent in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries,